› 2qq7

X-ray diffraction
2.38Å resolution

Crystal structure of drug resistant SRC kinase domain with irreversible inhibitor

Released:
DOI: 10.2210/pdb2qq7/pdb
PDB entry 2qq7 coloured by chain, front view.
PDB entry 2qq7 coloured by chain, side view.
PDB entry 2qq7 coloured by chain, top view.
Source organism: Gallus gallus
Primary publication:
Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR.
Michalczyk A, Klüter S, Rode HB, Simard JR, Grütter C, Rabiller M, Rauh D
Bioorg Med Chem 16 3482-8 (2008)
PMID: 18316192

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-132629 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Proto-oncogene tyrosine-protein kinase Src Chains: A, B
Molecule details ›
Chains: A, B
Length: 286 amino acids
Theoretical weight: 32.77 KDa
Source organism: Gallus gallus
Expression system: Escherichia coli BL21(DE3)
UniProt:
  • Canonical: P00523 (Residues: 251-533; Coverage: 53%)
Gene name: SRC
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand SR2 2 x SR2
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SLS BEAMLINE X10SA
Spacegroup: P1
Unit cell:
a: 42.22Å b: 63.36Å c: 75.06Å
α: 78.58° β: 89.08° γ: 89.87°
R-values:
R R work R free
0.217 0.214 0.266
Expression system: Escherichia coli BL21(DE3)

Quick links

Citations

16 review citations

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Recondo et al. (2018)
15 more

1 mention without citation

In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features.
Xiang et al. (2013)